We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Partway Group Plc | LSE:PTY | London | Ordinary Share | GB00B1235860 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.925 | 0.85 | 1.00 | 0.925 | 0.925 | 0.93 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Related Svcs, Nec | 41.6M | -1.72M | -0.0166 | -0.55 | 948.3k |
Date | Subject | Author | Discuss |
---|---|---|---|
06/12/2019 15:49 | Two can play at that game and both posts are worthless! | rafboy | |
06/12/2019 15:49 | NO PROFIT WARNING COMING IMHO | rafboy | |
05/12/2019 15:08 | PROFIT WARNING COMING IMHO | onjohn | |
05/12/2019 14:05 | Apologies Parity holders as my post probably more at home on the Integumen board. | flashheart | |
05/12/2019 14:04 | I've already been contemplating that Katsy as well. Not beyond the realms of possibility although a major transaction. Imagine the company in the making in the result though eh......mind boggling. Whatever the result and the reason behind the recent share price weakness (for no apparent reason as yet) I'm confident GB has all avenues covered and is building a beast to be reckoned with. | flashheart | |
05/12/2019 13:56 | Could this be a target for Integumen if indeed they are raising funds for an acquisition? c£10m Mcap with multople of that in revenue. If GB could cut cost and streamline the business like he's done for Integumen it could be a very profitable business. It would mean a massive dilution for SKIN shareholders though. | katsy | |
04/12/2019 06:46 | Well a few token shares purchased by director and its market cap went up bu a third. Really. REALLY !!! | my retirement fund | |
19/11/2019 09:54 | Agree. It's looking cheap with huge potential. | insideryou | |
19/11/2019 08:10 | Great if it would do the same rerating that SKIN had with data and be a multibagger | mulligut | |
19/11/2019 07:31 | I am an investor in SKIN but am watching here with interest. Low market cap, high turnover and a new management team all point to a possible multi-bagger even after a 50% rise. | parsons4 | |
15/11/2019 16:10 | ONJohnIs it not about time that you kept it shut? | thorne3 | |
15/11/2019 13:24 | Asking 9.5p now an that almost being paid. f | fillipe | |
15/11/2019 10:59 | Indeed, that deal could well prove very good for both companies. | rafboy | |
15/11/2019 10:39 | Yes and the price is moving up with the recent deal announcement of Integumen too | mulligut | |
15/11/2019 10:38 | Nice to see interest growing here with a few buys this morning. | rafboy | |
13/11/2019 10:10 | Todays news One sad sack doing a deal with an equally sad sack | onjohn | |
13/11/2019 09:29 | I bought shares here off the back of the SKIN partnership. I expect both companies to do well out of this deal. | soultrading | |
13/11/2019 07:58 | Parity Group PLC HoT regarding revenue share on AI data platformSource: UK Regulatory (RNS & others)TIDMPTYRNS Number : 1793TParity Group PLC13 November 201913 November 2019AIM: PTYParity Group PLC("Parity" or "Company")Parity shares revenue with Integumen plc to deliver AI data platform solutions to clientsParity announces that it has signed Heads of Terms with Integumen plc to enter a multi-year Framework Agreement ("Agreement") to be completed on or before the 18th of December 2019. It is envisaged that the Agreement will give Parity access to Integumen's Artificial Intelligent ("AI") software which it can supply across its client base which includes the National Health Service ("NHS"), Central Government and Private Institutional clients.This Agreement accelerates Parity's transformation from a predominately commoditised recruitment business to a data consultancy service provider of intelligent data management systems, extracting value using analytics, with a focus on return on investment for our Company's 100+ institutional clients. The software includes full GDPR compliance with secure cloud data migration from existing legacy systems to a digital workplace through the military grade encryption "Drive4Growth" AI platform powered by Integumen's Rinodrive.Combined benefits:-- Recurring shared revenue streams for both Parity and Integumen in 2020 -- Value-added proposition in demand from Parity clients with c. 3 to 5-year annual contracts -- Immediate access to 100+ public and private institutional clients -- Trusted approved vendor for Government and private sectors for over 45 years -- 700+ data experts and 50+ enterprise sales and office professionals -- Existing cross-over access to educational institutional research facilities -- Access to multiple industry, public and private sector distribution routes to market -- Well defined roadmap to next level business growth for both Parity and Integumen Since the appointment of the new CEO, in February 2019, there has been structural changes to the business. Client management focus is on increasing profitability. New senior management has reduced high-volume low-margin business to low-volume high-margin multi-line business development. This includes new, higher value data expert professional service offerings. Reduction in headcount of 35% has resulted in a rolling 12-month gross cost saving of GBP2m. Heading into 2020 with these changes and with today's agreement, the board expect the Company will deliver a right-sized company with higher margins, increased profitability leading to improved shareholder value.Matthew Bayfield, CEO of Parity Group plc, comments:"Parity is pleased to be partnering with Integumen and rolling out the Drive4Growth AI platform to our client base. We have been working with many of the same clients for 45 years, so we understand their needs. With healthcare sector data in 2020 expected to double every 73 days, our clients need to securely manage and extract greater value using analytics and AI in order to make important decisions. The Drive4Growth AI platform delivers on those requirements, increases revenue per client, increases client contract term and generates a higher margin, leading to greater profitability."Gerar | insideryou | |
20/9/2019 12:50 | Interesting first post cricket! | tiswas | |
20/9/2019 12:28 | This is an amazing achievement from a new CEO who in just 4 months has taken out over £1m of net costs, reorganised and refocused the business and made key new hires. With existing retained revenues of circa £44.5m, even if full year revenue allowing for the loss of the Scottish contract already announced,was only £70m the potential profits on margin improvement to just 5% would make the present market cap of the company look ridiculous. An exciting turnaround with big upside potential. | cricketcrazy | |
20/9/2019 10:08 | This is worthless o there is no IP. profit warning ans 3p beckoneth | onjohn | |
20/9/2019 10:03 | Pty has had many dawns, but it may be a long and difficult task. But what choice is there? Everything that is good or even middling, is getting taken out - Scysis, Statpro, Lombard, Stadium etc. | weatherman | |
20/9/2019 09:47 | Well, a loss, but cashflow positive (£0.2M) and debt paid down to just over £1m. Cash outflow of £0.4M related to restructuring implies that they could eradicate that debt with free cashflow in a year? Would you concur weatherman? New broom got things finally set for a recovery that has been waiting twenty years to happen? Or is that too optimistic? Back on the watch list after a few years of being dead dog (with fleas) in the kennel. G. | garth | |
20/9/2019 08:40 | That was not as bad as it could have been - with a positive change of direction towards a higher margin business. | weatherman | |
20/9/2019 08:39 | You have to believe in the turnaround to continue holding these, nothing much in the historic results that encourages. If anyone sees any broker comment I would appreciate a summary. | tiswas |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions